Spinal Metastasis
Cancer spread to the vertebral column causing pain and potential cord compression
ICD-10: C79.49 · tumors condition
Spinal metastasis is the most common malignant tumor affecting the spine, occurring in up to 40% of all cancer patients during the course of their disease. The vertebral column is the third most common site of metastatic disease overall, after the lung and liver. Breast, lung, prostate, and kidney cancers account for the majority of cases. Metastatic cells typically seed the vertebral body through Batson's venous plexus, causing osteolytic, osteoblastic, or mixed bone destruction. The resulting vertebral weakening leads to pathologic fracture, tumor extension into the epidural space, and potentially catastrophic spinal cord compression. The clinical presentation ranges from axial back pain (often nocturnal, progressive, not relieved by rest) to acute neurological emergency from epidural spinal cord compression (ESCC). The Spinal Instability Neoplastic Score (SINS) — incorporating tumor location, pain mechanics, bone lesion quality, spinal alignment, vertebral body collapse, and posterolateral involvement — guides surgical decision-making for spinal instability. Neurological deficits demand urgent MRI and multidisciplinary oncological team evaluation. Treatment is individualized based on tumor biology, systemic disease extent, expected survival, neurological status, and spinal stability. Options include radiation (conventional EBRT or stereotactic body radiotherapy — SBRT), surgery (separation surgery for ESCC followed by SBRT), vertebral augmentation (kyphoplasty for painful fractures), systemic therapy, and palliative care. The goal is pain control, neurological preservation, and meaningful quality of life.
Anatomy & Pathology
The vertebral body is the most common site of metastatic deposit. The posterior cortex of the vertebral body abuts the anterior epidural space; even modest tumor extension can impinge on the thecal sac and anterior cord. The pedicles and posterior elements are also frequently involved. Pathological compression fractures occur when osteolytic destruction erodes more than 50% of the vertebral body height, collapsing the anterior column onto the cord.
Symptoms
- Progressive back or neck pain that is constant, nocturnal, and not relieved by rest
- Pathologic vertebral compression fracture with acute pain worsening
- Neurological deficits: leg weakness, sensory loss, bowel or bladder dysfunction from ESCC
- Radicular pain from nerve root compression by tumor or fractured bone fragment
- Systemic symptoms: fatigue, weight loss, known prior cancer diagnosis
- Point tenderness to percussion over the affected vertebra
- Hypercalcemia symptoms: confusion, constipation, polyuria (in osteolytic metastases)
Causes & Risk Factors
- Hematogenous spread from breast, lung, prostate, or renal cell carcinoma (most common primary tumors)
- Direct extension from paravertebral lymphoma or retroperitoneal tumor
- Batson's paravertebral venous plexus as the route of seeding
- Osteolytic lesions (renal, thyroid, lung, breast) causing bone destruction
- Osteoblastic lesions (prostate, carcinoid) causing sclerotic vertebral involvement
Treatment Options
Conservative
- Stereotactic body radiotherapy (SBRT/SRS) — high-dose precise radiation achieving durable local tumor control without surgery
- Conventional external beam radiation therapy (EBRT) for radiosensitive tumors (lymphoma, myeloma, seminoma)
- Kyphoplasty or vertebroplasty for painful pathologic compression fractures without ESCC — cement augmentation restores height and reduces pain
Surgical
- Separation surgery (circumferential decompression without gross total tumor removal) to create epidural space for post-operative SBRT
- En bloc vertebrectomy for solitary metastasis from radioresistant tumors (renal cell, sarcoma) in selected patients with good prognosis
- Stabilization with percutaneous or open pedicle screw instrumentation for SINS-confirmed instability
When to see a spine specialist
Any cancer patient with new or worsening back pain should be evaluated for spinal metastasis with imaging. Seek emergency evaluation for any new neurological symptom — leg weakness, numbness, or loss of bladder or bowel control — as epidural spinal cord compression requires treatment within hours to preserve function. Do not attribute back pain in a cancer patient to muscle strain without imaging evaluation.
Specialists Who Treat Spinal Metastasis
Find a specialist who treats spinal metastasis
NPI-verified spine surgeons in your city.
- Austin, TX
- Charlotte, NC
- Chicago, IL
- Columbus, OH
- Dallas, TX
- Denver, CO
- Fort Worth, TX
- Houston, TX
- Indianapolis, IN
- Jacksonville, FL
- Los Angeles, CA
- Nashville, TN
- New York, NY
- Philadelphia, PA
- Phoenix, AZ
- San Antonio, TX
- San Diego, CA
- San Francisco, CA
- San Jose, CA
- Seattle, WA
Find a spine specialist near you
Browse NPI-listed spine surgeons and neurosurgeons who treat spinal metastasis. Filter by location, insurance, and availability.
Search spine specialists →Frequently Asked Questions
What is the SINS score and how does it affect treatment decisions?
The Spinal Instability Neoplastic Score (SINS) is a validated 6-item scoring system (0–18) that assesses spinal stability in metastatic disease. Scores 0–6 are stable (no surgical consultation needed), 7–12 are indeterminate (surgical consultation recommended), and 13–18 are unstable (surgical stabilization indicated). The score incorporates junction location, pain response to movement, bone lesion type (lytic/blastic), radiographic alignment, vertebral body collapse, and posterolateral element involvement. SINS helps oncologists and radiation oncologists identify patients who need surgical stabilization before or instead of radiation therapy.
What is separation surgery for spinal cord compression?
Separation surgery is a targeted surgical approach for epidural spinal cord compression from metastatic disease. Rather than attempting gross total tumor removal (which carries high morbidity), the surgeon performs circumferential decompression to create a 3–5 mm circumferential gap between the tumor and the spinal cord — the "separation" — enabling precise, ablative stereotactic body radiotherapy (SBRT) to be safely delivered to the remaining tumor mass. Combined separation surgery plus SBRT achieves durable local tumor control rates of 80–90% with acceptable complication rates.
Is surgery worthwhile for spinal metastasis if my prognosis is limited?
The decision must be individualized with a multidisciplinary team. Surgical decision-making frameworks (Tokuhashi, Tomita scores) incorporate expected survival, systemic disease extent, neurological status, and functional reserve. Patients with favorable tumor biology (breast, prostate, kidney), controlled systemic disease, and good functional status often benefit significantly from surgery even with metastatic disease. Patients with very short expected survival, poor functional reserve, or radiosensitive tumors (lymphoma, myeloma) often achieve equivalent or superior outcomes from radiation alone with less morbidity.